TY  - JOUR 
AU  - Robla, S.
AU  - Varela Calviño, R.
AU  - Ambrus, R.
AU  - Csaba, Noemí
PY  - 2023
SN  - 1879-0720
UR  - http://hdl.handle.net/20.500.11940/21002
AB  - The use of oral antibiotic therapy for the treatment of respiratory diseases as tuberculosis has promoted the appearance of side effects as well as resistance to these treatments. The low solubility, high metabolism, and degradation of drugs as...
LA  - eng
KW  - Humans
KW  - Nanocapsules
KW  - Powders
KW  - Protamines
KW  - Drug Delivery Systems
KW  - Rifabutin
KW  - Administration, Inhalation
KW  - Particle Size
KW  - Dry Powder Inhalers
KW  - Aerosols
TI  - A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery
DO  - 10.1016/j.ejps.2023.106442
T2  - European Journal of Pharmaceutical Sciences
KW  - AS Santiago
KW  - IDIS
VL  - 185
ER  -